26
Mar

San Diego’s Conatus Pharmaceuticals said its in-development liver disease drug came through in a Phase II trial, results the company believes create a path to late-stage development.

…read more

Source: Conatus heralds success for its NASH drug and plots Phase III

    

0 No comments